Company news
Quantum Biopharma Ltd. Subordinate Voting Shares Class B (CSE:QNTM) news
Quantum Biopharma Ltd. Subordinate Voting Shares Class B news releases on 6ix. Latest, Jun 3, 2019: Dr. Raza Bokhari, FSD Pharma Executive Co-Chairman and CEO…
View Quantum Biopharma Ltd. Subordinate Voting Shares Class B →
Press releases — page 6
Dr. Raza Bokhari, FSD Pharma Executive Co-Chairman and CEO to Participate in Biotech-Focused Panel at the 2019 BIO International Convention
June 3, 2019
FSD Pharma Congratulates High Tide on the Resumption of Retail Cannabis Licensing by AGLC in Alberta
May 31, 2019
Edward Brennan, Jr., M.D., FACS to Lead FSD Pharma BioSciences Division
May 28, 2019
FSD Pharma Welcomes All-Star Lineup of Cannabis Researchers to Scientific Advisory Board
May 20, 2019
FSD Pharma CEO Lays Out Roadmap in Exclusive Interview with CFN Media
May 10, 2019
FSD Pharma Investments Pay Off Amid Robust Expansion at Ontario Facility -- CFN Media
May 8, 2019
FSD Pharma Announces Research Agreement with Solarvest to Develop Algae-based, Pharma-grade Cannabinoids
May 7, 2019
FSD Pharma Reports 2018 Year-End Results
May 6, 2019
FSD Pharma provides update on status of 2018 year-end filings
May 2, 2019
FSD Pharma Doubles Down on Endocannabinoid-based Pain Management -- CFN Media
May 1, 2019
FSD Pharma and MP Kim Rudd Host Media Event at Cobourg Production Facility
April 26, 2019
FSD Pharma Announces Share Exchange Transaction with Aura Health
April 24, 2019
InvestmentPitch Media Video Discusses FSD Pharma and its New Additional License to Sell Cannabis for Medical Purposes - Video Available on Investmentpitch.com
April 23, 2019
FSD Pharma Receives Cannabis Sales License from Health Canada
April 22, 2019
FSD Pharma to Present at Arcview Investor Forum
April 17, 2019
FSD Pharma Appoints Charles Pollack Jr. MD, FACEP as Chairman of the Scientific Advisory Board
April 4, 2019